Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in Resectable ESCC
Clinical trial NCT07490002 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07490002
- Sponsor
- Changhai Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-06
- Primary completion
- 2028-11-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.